Ventyx Biosciences, Inc.
VTYXDelisted Mar 4, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001851194
Ventyx Biosciences, Inc. was delisted on Mar 4, 2026; its insiders filed their last Form 4 on Mar 4, 2026; 139 institutions reported holding it in 13F filings for Q4 2025, worth $471.6M in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Ventyx Biosciences, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 117 | 1 | 118 | +2 |
| Shares | 57.3M | 4.77M | 52.5M | +344 (0.0%) |
| Value | $132.3M | $11.0M | $114.4M | −$6.82M (−5.6%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Ventyx Biosciences, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 4,911,397 | $10.7M | 0.00% |
| Renaissance Technologies LLC | 313,700 | $683.9K | 0.00% |
| Bridgeway Capital Management, LLC | 200,000 | $436.0K | 0.01% |
| UBS Oconnor LLC | 200,000 | $436.0K | 0.01% |
| Marshall Wace, LLP | 178,514 | $389.2K | 0.00% |
| XTX Topco Ltd | 112,713 | $245.7K | 0.02% |
| LMR Partners LLP | 100,000 | $218.0K | 0.00% |
| ExodusPoint Capital Management, LP | 76,007 | $166.0K | 0.00% |
| SEI Investments Co | 35,799 | $78.0K | 0.00% |
| Algert Global LLC | 26,490 | $57.7K | 0.00% |
| Intech Investment Management LLC | 19,161 | $41.8K | 0.00% |
| Bank of Montreal | 17,702 | $40.9K | 0.00% |
| AJOVista, LLC | 12,550 | $27.4K | 0.12% |
| Palumbo Wealth Management LLC | 12,140 | $26.5K | 0.01% |
| Federated Hermes, Inc. | 7,247 | $15.8K | 0.00% |
| Asset Dedication, LLC | 4,116 | $8.97K | 0.00% |
| Bessemer Group Inc | 520 | $1.00K | 0.00% |
| Sterling Capital Management LLC | 193 | $421 | 0.00% |
| Continuum Advisory, LLC | 200 | $394 | 0.00% |
| Capital Performance Advisors LLP | 173 | $377 | 0.00% |
Sold out (18)
Institutions that held Ventyx Biosciences, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Capital International Investors | 5,247,646 | $12.1M |
| Opaleye Management Inc. | 1,190,000 | $2.75M |
| Parkman Healthcare Partners LLC | 1,160,022 | $2.68M |
| Woodline Partners LP | 379,175 | $875.9K |
| BIT Capital GmbH | 304,760 | $704.0K |
| Cubist Systematic Strategies, LLC | 149,500 | $345.3K |
| Jump Financial, LLC | 105,836 | $244.5K |
| Verition Fund Management LLC | 79,532 | $183.7K |
| Sherbrooke Park Advisers LLC | 75,890 | $175.3K |
| Dark Forest Capital Management LP | 38,126 | $88.1K |
| Dynamic Technology Lab Private Ltd | 29,947 | $69.0K |
| Carnegie Capital Asset Management, LLC | 15,000 | $34.6K |
| Simplex Trading, LLC | 12,482 | $28.0K |
| Dimensional Fund Advisors LP | 11,658 | $27.0K |
| AlphaCentric Advisors LLC | 10,000 | $23.1K |
| Optiver Holding B.V. | 498 | $1.15K |
| Riggs Asset Managment Co. Inc. | 171 | $396 |
| GAMMA Investing LLC | 22 | $51 |
Not filed for Q3 2024 yet (1)
Institutions that held Ventyx Biosciences, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 4,771,657 | $11.0M |